BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35304037)

  • 81. Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II.
    Wang RY; Cambray-Forker EJ; Ohanian K; Karlin DS; Covault KK; Schwartz PH; Abdenur JE
    Mol Genet Metab; 2009 Dec; 98(4):406-11. PubMed ID: 19748810
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Improvements in sensorineural hearing loss after cord blood transplant in patients with mucopolysaccharidosis.
    Da Costa V; O'Grady G; Jackson L; Kaylie D; Raynor E
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1071-6. PubMed ID: 23165382
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Metabolic Syndrome and Cardiovascular Risk Factors after Hematopoietic Cell Transplantation in Severe Mucopolysaccharidosis Type I (Hurler Syndrome).
    Braunlin E; Steinberger J; DeFor T; Orchard P; Kelly AS
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1289-1293. PubMed ID: 29409846
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
    Wyatt K; Henley W; Anderson L; Anderson R; Nikolaou V; Stein K; Klinger L; Hughes D; Waldek S; Lachmann R; Mehta A; Vellodi A; Logan S
    Health Technol Assess; 2012; 16(39):1-543. PubMed ID: 23089251
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Longitudinal trajectories of intellectual and adaptive functioning in adolescents and adults with Williams syndrome.
    Fisher MH; Lense MD; Dykens EM
    J Intellect Disabil Res; 2016 Oct; 60(10):920-32. PubMed ID: 27273269
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Timing is everything: Clinical courses of Hunter syndrome associated with age at initiation of therapy in a sibling pair.
    Grant N; Sohn YB; Ellinwood NM; Okenfuss E; Mendelsohn BA; Lynch LE; Braunlin EA; Harmatz PR; Eisengart JB
    Mol Genet Metab Rep; 2022 Mar; 30():100845. PubMed ID: 35242576
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Early treatment is associated with improved cognition in Hurler syndrome.
    Poe MD; Chagnon SL; Escolar ML
    Ann Neurol; 2014 Nov; 76(5):747-53. PubMed ID: 25103575
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II.
    Chatham CH; Taylor KI; Charman T; Liogier D'ardhuy X; Eule E; Fedele A; Hardan AY; Loth E; Murtagh L; Del Valle Rubido M; San Jose Caceres A; Sevigny J; Sikich L; Snyder L; Tillmann JE; Ventola PE; Walton-Bowen KL; Wang PP; Willgoss T; Bolognani F
    Autism Res; 2018 Feb; 11(2):270-283. PubMed ID: 28941213
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).
    Tolar J; Park IH; Xia L; Lees CJ; Peacock B; Webber B; McElmurry RT; Eide CR; Orchard PJ; Kyba M; Osborn MJ; Lund TC; Wagner JE; Daley GQ; Blazar BR
    Blood; 2011 Jan; 117(3):839-47. PubMed ID: 21037085
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The natural history of MPS I: global perspectives from the MPS I Registry.
    Beck M; Arn P; Giugliani R; Muenzer J; Okuyama T; Taylor J; Fallet S
    Genet Med; 2014 Oct; 16(10):759-65. PubMed ID: 24675674
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MPS I: Early diagnosis, bone disease and treatment, where are we now?
    Kingma SDK; Jonckheere AI
    J Inherit Metab Dis; 2021 Nov; 44(6):1289-1310. PubMed ID: 34480380
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control.
    Berg AT; Smith SN; Frobish D; Beckerman B; Levy SR; Testa FM; Shinnar S
    Pediatrics; 2004 Sep; 114(3):645-50. PubMed ID: 15342834
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Regression of ventriculomegaly following medical management of a patient with Hurler syndrome.
    Liang J; Singhal A
    J Neurosurg Pediatr; 2016 May; 17(5):537-9. PubMed ID: 26745646
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Assessment of Activity of Daily Life in Mucopolysaccharidosis Type II Patients with Hematopoietic Stem Cell Transplantation.
    Suzuki Y; Taylor M; Orii K; Fukao T; Orii T; Tomatsu S
    Diagnostics (Basel); 2020 Jan; 10(1):. PubMed ID: 31963134
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Neurobehavioural outcomes in children after In-Hospital cardiac arrest.
    Slomine BS; Silverstein FS; Christensen JR; Holubkov R; Telford R; Dean JM; Moler FW;
    Resuscitation; 2018 Mar; 124():80-89. PubMed ID: 29305927
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
    Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
    J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Neurological outcomes after hematopoietic stem cell transplantation for cerebral X-linked adrenoleukodystrophy, late onset metachromatic leukodystrophy and Hurler syndrome.
    Saute JA; Souza CF; Poswar FO; Donis KC; Campos LG; Deyl AV; Burin MG; Vargas CR; Matte UD; Giugliani R; Saraiva-Pereira ML; Vedolin LM; Gregianin LJ; Jardim LB
    Arq Neuropsiquiatr; 2016 Dec; 74(12):953-966. PubMed ID: 27991992
    [TBL] [Abstract][Full Text] [Related]  

  • 98. MPS II: adaptive behavior of patients and impact on the family system.
    Needham M; Packman W; Rappoport M; Quinn N; Cordova M; Macias S; Morgan C; Packman S
    J Genet Couns; 2014 Jun; 23(3):330-8. PubMed ID: 24190099
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler.
    Ferrara G; Maximova N; Zennaro F; Gregori M; Tamaro P
    Pediatr Transplant; 2014 May; 18(3):E96-9. PubMed ID: 24483599
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.
    Pastores GM; Arn P; Beck M; Clarke JT; Guffon N; Kaplan P; Muenzer J; Norato DY; Shapiro E; Thomas J; Viskochil D; Wraith JE
    Mol Genet Metab; 2007 May; 91(1):37-47. PubMed ID: 17336562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.